Clinical Trials Browser

Phase 2 × Rectal Neoplasms × camrelizumab × Clear all

NCT06304545 2024-03-12

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT04340401 2020-07-09

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms